| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MannKind Corporation (NASDAQ: MNKD)
MNKD Technical Analysis
3
| As on 31st Oct 2017 MNKD Share Price closed @ 3.29 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.51 & Buy for SHORT-TERM with Stoploss of 2.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MNKD Share Price
| Open | 3.46 | Change | Price | % |
| High | 3.50 | 1 Day | -0.14 | -4.08 |
| Low | 3.28 | 1 Week | 0.00 | 0.00 |
| Close | 3.29 | 1 Month | -1.99 | -37.69 |
| Volume | 2790695 | 1 Year | 2.63 | 398.48 |
| 52 Week High 6.96 | 52 Week Low 0.46 | ||||
NASDAQ USA Most Active Stocks
| YHOO | 52.58 | 0.00% |
| FNFG | 10.18 | -0.20% |
| DELL | 13.86 | 0.22% |
| RFMD | 16.59 | -2.07% |
| MU | 44.31 | 6.39% |
| RIMM | 13.03 | 0.39% |
| BBEP | 0.12 | 0.00% |
| GTAT | 0.44 | 0.00% |
| SUSQ | 14.20 | -0.77% |
| INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MNKD Daily Charts |
MNKD Intraday Charts |
Whats New @ Bazaartrend |
MNKD Free Analysis |
|
|
MNKD Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 3.49 |
| RESISTANCE | 3.41 |
| SUPPORT | 3.17 |
| SUPPORT | 3.09 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
MNKD Target for Month January
| 4th UP TARGET | 12.83 |
| 3rd UP TARGET | 9.77 |
| 2nd UP TARGET | 7.88 |
| 1st UP TARGET | 5.99 |
| 1st DOWN TARGET | 0.59 |
| 2nd DOWN TARGET | -1.3 |
| 3rd DOWN TARGET | -3.19 |
| 4th DOWN TARGET | -6.25 |
MNKD Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
MNKD Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
MannKind Corporation ( NASDAQ USA Symbol : MNKD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MNKD Business Profile
MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company�s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia. The AFREZZA inhalation powder is centered on a class of potential of hydrogen (pH)-sensitive organic molecules. AFREZZA utilizes its Technosphere formulation technology. As of December 31, 2011, MannKind had not generated any product revenues. As of December 31, 2011, the AFREZZA clinical program had involved 61 different studies of AFREZZA and over 5,600 adult patients.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
